Leptospermum Scoparium Honey & Wound Care for Pressure Ulcers

Status Withdrawn

Clinical Trial Summary

The investigators hypothesize that the use of leptospermum scoparium honey as a type of dressing and/or debridement agent on stage III or IV pressure ulcers has an increased efficacy and safety compared to the current treatment protocol that includes the use of hydrogel/Vaseline, collagenase, and silver alginate dressings as the standard of care. Utilizing a non-inferiority trial, it is expected that the use of leptospermum scoparium as a treatment for Stage III and Stage IV pressure ulcers will not be inferior to the comparison treatment of standard of care wound dressings. Moreover, this research design will enable the research team to determine if the honey based dressings are equivalent to or superior to the comparison treatment.

Therefore, the investigators specific study objectives are as follows:

1. Primary Objectives: Determine if the use of honey as an alternative treatment will reduce site inflammation/irritation and pain associated with pressure ulcers compared to the standard treatment options. Specifically, the investigators will monitor patient PUSH scores, Braden Risk Scale scores, granulation and/or epithelial tissue progression, length of time to heal, patient pain assessments via the Wong Baker Face or Numeric Scale, wound odors, and incidence of adverse events (measured by allergies, stinging sensations, bacterial infections that warrant antibiotic intervention, etc.).

2. Secondary Objective: Patients in the honey treatment group will have lower costs per healed ulcer than patients in the standard collagenase treatment group.

Clinical Trial Description

Design: Non-inferiority Trial. This design is intended to demonstrate that Leptospermum scoparium Honey treatment is no worse than the standard treatment for pressure ulcers.

Data Collection Procedures:

Members of the research team will administer all wound care treatments on all of the patients in this research project. After initial evaluation and documentation of the presence of pressure ulcers, patients with Stage III and Stage IV ulcers are randomized into the two groups; treatment and control. Patients that develop nosocomial Stage III and Stage IV pressure ulcers will also be included in this study and randomly placed into one of the groups. The following protocol will be followed. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02689310
Study type	Interventional
Source	New York City Health and Hospitals Corporation
Contact
Status	Withdrawn
Phase	Phase 4
Start date	March 1, 2018
Completion date	April 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02930590` - Effects of Different Support Surfaces on the Properties Skin After Loading	N/A
Completed	`NCT02224404` - Post Market Clinical Follow-up Investigation to Evaluate Performance and Safety on Pressure Ulcers, PU, When Using Exufiber as Intended	N/A
Completed	`NCT01965444` - A Test of the Investigational SEM Scanner	N/A
Withdrawn	`NCT00623948` - Implanted Gluteal Stimulation System for Pressure Sore Prevention	N/A
Terminated	`NCT01433159` - Comparison of HP011-101 to Standard Care for Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury	Phase 2
Recruiting	`NCT01355666` - Silk-Like Fabric for the Prevention of Pressure Sores in a Long Term Care Setting	N/A
Completed	`NCT01403272` - Evaluate the Efficacy of a Silk-Like Fabric for the Prevention of Pressure Sores in a Long Term Care Setting	N/A
Completed	`NCT01008254` - Interdisciplinary Mobility Approach To Reduction Of Facility-Acquired Pressure Ulcers	Phase 2/Phase 3
Completed	`NCT00971048` - Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds	N/A
Terminated	`NCT00762138` - The AutoloGel™ Post-Market Surveillance (TAPS) Program	N/A
Completed	`NCT00507650` - Increasing Fluids in Older Adults to Prevent & Treat Pressure Ulcers	N/A
Completed	`NCT01877681` - Reference Nurse Program for Pressure Ulcers in Primary Care	Phase 2
Completed	`NCT01232764` - Pressure Ulcer Multi-disciplinary Teams Via Telemedicine (PUMTT): A Trial in Long Term Care	Phase 3
Completed	`NCT06374563` - Tackling Pressure Ulcer Via Bee Venom Phonophoresis	N/A
Completed	`NCT03070925` - Prospective PuraPly™ AM Case Series Study	N/A
Completed	`NCT02894437` - Qualitative Study of Preventive Organization of the Pelvic Bedsores Injured Spinal Cord
Completed	`NCT01348581` - Use of Fish Skin Extracellular Matrix (ECM) to Facilitate Chronic Wound Healing	N/A
Completed	`NCT00771238` - Pilot Study of Incidence and Change in Existing Pressure Ulcers: TC500 Bed Compared With Standard Beds	N/A
Completed	`NCT00763282` - Self-Management to Prevent Ulcers in Veterans With SCI (Spinal Cord Injury)	N/A
Completed	`NCT01885962` - Development and Feasibility of an Internet Intervention for Adults With Spinal Cord Injury to Prevent Pressure Ulcers	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Leptospermum Scoparium Honey and Wound Care for Pressure Ulcers

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms